Table 2 Characteristics of patients from the validation set (Group B)
VariablePatientsNRsSVRs
No.29920
Gender (male, n (%))22 (76)8 (89)14 (70)
Age (years)45.1 (9.1)48.2 (10.6)43.6 (8.3)
Source of infection (n (%))
    Blood transfusion3 (10.3)1 (11)2 (10)
    Intravenous drug use9 (31.1)3 (33)6 (30)
    Unknown17 (58.6)5 (66)12 (60)
ALT (IU/l, median)129 (70)120 (49)132 (79)
HCV genotype (n)
    11789
    2202
    3606
    4413
    5000
Stage (n)
    F1716
    F21349
    F3725
    F4220
  • ALT, alanine aminotransferase; HCV, hepatitis C virus; NRs, non-responders; SVRs, sustained virological responders.